Most GLP-1 side effects are the same whether you are a man or a woman: the nausea, the slowed digestion, the fatigue. They are not listed as sex-specific on the label. But a handful of things matter more if you are a woman, and almost no one warns you about them up front. Two stand out. The first is specific to tirzepatide (Mounjaro, Zepbound), not semaglutide: if you take it and rely on the birth control pill, the medication can make the pill less reliable for a few weeks after you start and after every dose increase, so you may need a backup method. And as the weight comes off, your cycle, your fertility, and even your hair can shift. None of this means something is wrong with you. It means your body is responding. This is general information, not medical advice.
Are the side effects really different for women?
First, the honest answer, because you deserve one. The common side effects of GLP-1 receptor agonists, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are nausea, vomiting, diarrhea, constipation, and fatigue. These hit hardest when you first start and at each dose increase, and they ease for most people as the body settles, which we map out in how long GLP-1 side effects last. The FDA labels do not list these as worse for women than for men. So if you have read somewhere that "women get more nausea," know that the picture is messier than a clean yes.
Here is what the research actually shows. Some real-world data hints that women report digestive side effects more often, and may stop the medication because of them more often than men, though that trend has not been confirmed as statistically significant. A large semaglutide trial (SUSTAIN 6) found no difference between the sexes at all, as noted in a review of sex differences in GLP-1 response. The reviewers are careful to say the reasons are not settled, and they do not pin any difference on body size or on being a woman. In other words: if you feel rougher than you expected, you are not imagining it and you are not weak. A slower, prescriber-guided dose increase is the usual answer, and that is a conversation to have with the person who prescribed it.
What is genuinely different for women is mostly about hormones, contraception, fertility, and how rapid weight loss touches the body. That is the rest of this page.
The birth control interaction (this one is important)
If there is one thing on this page to remember, it is this. Tirzepatide (Mounjaro and Zepbound) can make oral birth control pills less effective. This is specific to tirzepatide, not semaglutide.
The reason is mechanical, not mysterious. Tirzepatide slows down how fast your stomach empties, and that can change how much of a swallowed pill your body actually absorbs. Eli Lilly's own medical guidance explains that "tirzepatide delays gastric emptying, and thereby has the potential to impact the absorption of oral medications," and that this slowdown "is largest after the first dose and diminishes over time."
So here is what the label advises, in plain terms. If you use oral hormonal contraceptives, switch to a non-oral method, or add a barrier method like condoms, for 4 weeks after you start tirzepatide and for 4 weeks after each dose increase, per Lilly's guidance and the MotherToBaby fact sheet. The good news: birth control that is not swallowed (the patch, the ring, the shot, an implant, or an IUD) is not affected the same way, because it does not have to survive your digestion. This is a quick, two-minute conversation with your prescriber or pharmacist, and it is one worth having before your next refill rather than after.
"Ozempic babies": why unplanned pregnancies happen
You may have seen the phrase "Ozempic babies" in the news. It describes the wave of unplanned pregnancies reported by women on GLP-1 medications, and there is a real, understandable reason behind it. As Cleveland Clinic explains, it comes down to two things happening at once.
The first is the birth control interaction above: if the pill is quietly working less well during those titration weeks, an unplanned pregnancy becomes more possible. The second is gentler and, for many women, surprising. Losing a meaningful amount of weight can restore ovulation in women who were not ovulating regularly before, which makes pregnancy more likely than it used to be. That is especially true for women with PCOS (more on that next). So you can be more fertile than you have been in years without anything feeling different. If pregnancy is not your plan right now, that is exactly why the contraception step matters so much.
Cycle changes, PCOS, and fertility
If your period shifts after starting the shot, you are far from alone, and it is usually a downstream effect of weight loss rather than the drug acting on your uterus directly. For many women, cycles that were irregular become more regular. For women with PCOS specifically, this can be one of the more welcome changes.
The evidence here is early but consistent. Researchers running the RESTORE trial at the University of Colorado reported that substantial weight loss during semaglutide treatment was linked to early improvements in reproductive health, with the benefits showing up sooner than the team expected. As one expert told Medical News Today, weight reduction is known to improve hormone balance, ovarian function, and fertility in women with PCOS. Excess body fat produces extra estrogen, which can throw off the cycle, so as the weight comes down, that signal often settles.
Two honest caveats. These studies are small and ongoing, so this is promising rather than proven. And no GLP-1 medication is FDA-approved as a fertility treatment, so any use for that reason is a decision to make with your doctor, not something to assume.
Pregnancy and trying to conceive
This part is simple and firm. GLP-1 medications are not recommended during pregnancy. Weight loss is not a pregnancy goal, and animal studies have shown the potential for fetal harm, so the guidance is to stop before trying to conceive.
How long before depends on the medication, because each clears the body at a different pace. The Ozempic (semaglutide) FDA label advises discontinuing it "at least 2 months before a planned pregnancy due to the long washout period." For tirzepatide, the MotherToBaby fact sheet notes it can take about 30 days on average for most of the drug to leave the body, and many clinicians use a washout of several weeks before conception. The exact timing is your prescriber's call, so loop them in early if a pregnancy is on your horizon.
And if you find out you are pregnant while on a GLP-1, the advice is the same across the board: stop the medication and contact your clinician promptly. You do not need to panic, and you should not wait.
Hair loss with rapid weight loss
This one surprises and upsets a lot of women, so let us name it plainly: yes, some hair shedding can happen, and yes, it is almost always temporary.
What you are seeing is usually telogen effluvium, a fancy name for a simple thing. Any big physical stress on the body, including losing weight quickly, can nudge a batch of hair follicles into their resting phase early. A couple of months later, those hairs shed together, which is why your part or your shower drain can suddenly look alarming. It tends to show up 2 to 3 months after the weight loss really gets going. In the obesity trials, hair loss was reported by about 3% of people on Wegovy and 4 to 5% on Zepbound, versus roughly 1% on placebo, so it is real but not the norm.
The reassuring part is that the follicles are resting, not dead. As your weight and intake stabilize, shedding usually settles and regrowth follows over the next several months, though it is slower to see than it was to lose. Eating enough protein and keeping iron in a healthy range support the process, and that is worth a quick word with your prescriber if the shedding is heavy or dragging on. The same rapid weight loss that touches your hair can also change your face, which we cover in facial volume loss, or "Ozempic face".
A note on vaginal and genital symptoms
Because this comes up constantly, here is the accurate version. Genital yeast infections are a known side effect of a different class of diabetes medication called SGLT2 inhibitors, not of GLP-1 receptor agonists. If you have read that "Ozempic causes yeast infections," that wiring crossed two unrelated drug classes somewhere along the way.
Vaginal and genital changes are not listed on the GLP-1 label, and honestly they are under-studied in this context. Some women do report dryness or shifts that tend to track with hormonal changes and rapid weight loss rather than the drug acting on that tissue directly. We would rather tell you that the evidence is thin than pretend it is settled. Our deeper page on vaginal and menstrual changes walks through what is known, what is not, and the SGLT2 distinction in full.
When to call someone
The changes on this page are mostly normal and mostly manageable. The point of knowing the warning signs is so you can sort the ordinary from the urgent quickly and stop second-guessing the ordinary ones.
Everything else on this page is the kind of thing to bring to your next appointment, not the emergency room.
Questions people ask at 11pm
Does my birth control still work on Mounjaro or Zepbound? Maybe not fully, for a few weeks. Tirzepatide can make oral birth control pills less reliable for 4 weeks after you start and after each dose increase, so the label advises adding a barrier method or switching to a non-oral option during those windows. Non-oral methods like the IUD, implant, shot, ring, or patch are not affected the same way. This applies to tirzepatide, not semaglutide.
Can the shot make me more fertile? It can, indirectly. Losing a meaningful amount of weight can restore regular ovulation, especially for women with PCOS, which is one reason "Ozempic babies" became a headline. It is not approved as a fertility treatment, and it is not recommended during pregnancy, so if you are trying to conceive, plan the timing with your prescriber.
Will my hair grow back? Almost always, yes. The shedding is usually telogen effluvium from rapid weight loss, where follicles rest and then shed together a couple of months later. As your weight stabilizes, the follicles wake back up and regrowth follows over the next several months. Heavy or persistent shedding is worth a check for things like low iron.
How we reviewed this: this page was written from primary and authoritative sources, including the Mounjaro/Zepbound contraception guidance from Eli Lilly, the MotherToBaby tirzepatide fact sheet, the Ozempic FDA label, Cleveland Clinic on "Ozempic babies", and the RESTORE fertility findings from the University of Colorado. Where the evidence is early or thin, like the fertility data and the vaginal symptom picture, we say so rather than overstating it. See our editorial and review policy and sourcing standards.
Every medical claim above is cited to a primary source such as an FDA label, the NIH, or a named clinical trial. See how we review and our sourcing & fact-check standards.